Archive for October, 2003

h1

106761713086775597

October 31, 2003

In Initial Finding, F.D.A. Calls Cloned Animals Safe as Food
Milk and meat from cloned animals are safe to consume, the Food and Drug Administration has tentatively concluded, a finding that could eventually clear the way for such products to reach supermarket shelves and for cloning to be widely used to breed livestock.

Advertisements
h1

106761407065836652

October 31, 2003

Biotech Startups: Take Your Time
Until startups’ products are close to gaining approval, there’s no reason why smart investors would want to share the risks

h1

106761397054766771

October 31, 2003

Has the debate on GM crops been misleading?
More than a hundred scientists have written to Tony Blair, complaining about the handling of the public debate on genetically modified crops.

They say that they feel ‘undermined’ by the government’s failure to correct false claims.

h1

106754483901995731

October 30, 2003

Are Adult Stem Cells a Bust?
Opponents of research on embryonic stem cells have insisted that adult stem cells are a therapeutically superior and ethically more acceptable alternative. However, a new report in Nature finds that adult stem cells may not be the panacea that the bioconservative movement had hoped.

h1

106753262632110379

October 30, 2003

Is the US pharmaceuticals industry losing its way?
The EU generally looks to the US as its model for pharmaceuticals innovation. But US companies are showing signs of vulnerability due to competition from generics and a lack of new ‘blockbuster’ drugs.

h1

106753247732750012

October 30, 2003

U.S. drug companies curb supplies to Canadian exporters
As the political fight over drug imports into the United States intensifies, several top industry executives say that they have been effective in denying supplies to Canadian pharmacies that ship to America.

h1

106753216203518432

October 30, 2003

The next big thing is…
According to the most recent MoneyTree Survey, a report put together by PricewaterhouseCoopers, Thomson Venture Economics and the National Venture Capital Association, which tracks venture capital investments, biotech and medical equipment firms are really the next big thing …
Although overall VC funding in the third quarter dipped 8 percent from the second quarter, investments in so-called life science firms increased 14 percent.